期刊文献+

稽留流产采用舌下含服、阴道给药及口服给予米索前列醇终止妊娠的优劣差异 被引量:5

Advantages and disadvantages of sublingual administration, vaginal administration and oral misoprostol for termination of pregnancy in missed abortion
下载PDF
导出
摘要 目的比较稽留流产采用舌下含服、阴道给药及口服米索前列醇终止妊娠的效果。方法 81例稽留流产患者,按照随机数字表法分为A组、B组和C组,各27例。A采用舌下含服米索前列醇, B组采用阴道给予米索前列醇, C组采用口服米索前列醇。比较三组的临床效果、子宫收缩时间、排胎时间、排胎2 h内出血量及不良反应发生情况。结果 A组有效率为92.59%, B组有效率为70.37%,C组有效率为40.74%;A组有效率高于B组和C组, B组高于C组,差异具有统计学意义(P<0.05)。A组患者的子宫收缩时间(28.14±4.58)min、排胎时间(9.59±2.67)h明显短于B组患者的(35.73±5.82)min、(16.92±3.47)h和C组患者的(36.02±6.16)min、(18.15±3.61)h,排胎2 h出血量(90.43±18.29)ml明显少于B组患者的(120.27±23.17)ml和C组患者的(118.53±18.82)ml,差异具有统计学意义(P<0.05)。A组患者腹痛发生率明显高于B、C组患者,差异有统计学意义(P<0.05);三组患者阴道流血、胃肠道反应发生率比较差异无统计学意义(P>0.05)。结论稽留流产采用舌下含服米索前列醇治疗的临床疗效明显优于阴道及口服给药,但腹痛现象明显,临床上应合理选择治疗方式。 Objective To compare the effect of sublingual administration, vaginal administration and oral administration of misoprostol for termination of pregnancy in missed abortion. Methods A total of 81 patients with missed abortion were divided by random number table into group A, B and C, with 27 cases in each group. Group A received sublingual administration of misoprostol, group B received vaginal administration of misoprostol, and group C received oral administration of misoprostol. Comparison were made on clinical effect, uterine contraction time, abortion time, bleeding volume within 2 h of abortion and occurrence of adverse reactions in three groups. Results Group A had effective rate as 92.59%, which was 70.37% in group B and.40.74% in group C. Group A had higher effective rate than group B and C, group B was higher than group C. Their difference was statistically significant (P<0.05). Group A had obviously shorter uterine contraction time as (2.114 ± 4.58) min, abortion time as (9.59 ± 2.67) h than (35.73 ± 5.82) min,(16.92 ± 3.47) h in group B, and (36.02 ± 6.16) min,(18.15 ± 3.61) h in group C, and obviously less bleeding volume within 2 h of abortion as (90.43 ± 18.29) ml than (120.27 ± 23.17) ml in group B and (118.53 ± 18.82) ml in group C. Their difference was statistically significant (P<0.05). Group A had obviously higher incidence of abdominal pain than group B and C, and the difference was statistically significant (P<0.05). Three groups had no statistically significant in incidence of vaginal bleeding and gastrointestinal reactions (P>0.05). Conclusion Sublingual administration of misoprostol shows obviously better clinical efficacy than viginal and oral administration, but the abdominal pain is obvious. So the treatment method should be rationally selectod in clinic.
作者 黎小红 黎绮红 阮翠梨 LI Xiao-hong;LI Qi-hong;RUAN Cui-li(Department of Obstetrics and Gynecology, Zengcheng Hospital of Traditional Chinese Medicine, Guangzhou 511300, China)
出处 《中国实用医药》 2019年第9期3-4,共2页 China Practical Medicine
关键词 稽留流产 舌下含服 阴道给药 米索前列醇 终止妊娠 Missed abortion Sublingual administration Vaginal administration Misoprostol Termination of pregnancy
  • 相关文献

参考文献3

二级参考文献29

  • 1任彩红,张珂.米非司酮配伍米索前列醇在不同孕周的应用研究[J].实用医技杂志,2006,13(7):1109-1110. 被引量:8
  • 2乐杰.妇产科学[M].6版.北京:人民卫生出版社,2005:145.
  • 3Christiansen M, Pihl K, Hedley PL, et al.ADAM 12 may be used to reduce the false positive rate of first trimester combined screening for Down syndrome[J].Prenat Diagn, 2010, 30 (2) : 110-114.
  • 4Irwin JC, Suen LF, Faessen GH, et al. Insulin-like growth factor (IGF) -I Iinhibition of endometrial stromal cell tissue inhibitor of metalloproteinase-3 and IGF-binding protein-1 suggests paracrine interactions at the deciduas :trophoblast interface during human implantation[J].J Clin Endocrinol Metab, 2011,6 ( 5 ) :2060-2064.
  • 5Sia D, Hoshida Y, Villanueva A, et al.Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have diff erent outcomes[J].Gastroenterology, 2013, 144:829-840.
  • 6Andersen JB, Spee B, Blechacz BR, et al.Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors[J].Gastroenterology, 2012, 142:1021-1031.
  • 7Khalil A, Cowans NJ, Spencer K, et al.First trimester maternal serum placental protein 13 for the prediction of preeclampsia in women with a priori high risk[J].Prenat Diagn, 2009, 29 (8) : 781-789.
  • 8Vuorela P, Carpen O, Tulppala M, et al.VEGF, its receptors and the tie receptors in recurrent miscarriage[J].Mol Hum Reprod, 2010,6 (3) :276-282.
  • 9Magdoud K, Dendana M, Herbepin V, et al.Identification of specific vascular endothelial growth factor susceptible and protective haplotypes associated recurrent spontaneous miscarriages[J].Hum Reprod, 2012,27 (5) :1536-1541.
  • 10Ouyang G, Wang Z, Fang X, et al.Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem ceUs[J].Cell Mol Life Sci, 2010, 67 (15) :2605-2618.

共引文献31

同被引文献39

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部